İ. Ç. Benlidayı Et Al. , "Denosumab is effective among patients with postmenopausal osteoporosis regardless of prior fracture status.," 13th Mediterranean Congress of Physical & Rehabilitation Medicine , Marrakesh, Morocco, pp.40, 2019
Benlidayı, İ. Ç. Et Al. 2019. Denosumab is effective among patients with postmenopausal osteoporosis regardless of prior fracture status.. 13th Mediterranean Congress of Physical & Rehabilitation Medicine , (Marrakesh, Morocco), 40.
Benlidayı, İ. Ç., Gökçen, N., ŞEN, E. İ., Güzel, R., & SİNDEL, D., (2019). Denosumab is effective among patients with postmenopausal osteoporosis regardless of prior fracture status. . 13th Mediterranean Congress of Physical & Rehabilitation Medicine (pp.40). Marrakesh, Morocco
Benlidayı, İlke Et Al. "Denosumab is effective among patients with postmenopausal osteoporosis regardless of prior fracture status.," 13th Mediterranean Congress of Physical & Rehabilitation Medicine, Marrakesh, Morocco, 2019
Benlidayı, İlke Ç. Et Al. "Denosumab is effective among patients with postmenopausal osteoporosis regardless of prior fracture status.." 13th Mediterranean Congress of Physical & Rehabilitation Medicine , Marrakesh, Morocco, pp.40, 2019
Benlidayı, İ. Ç. Et Al. (2019) . "Denosumab is effective among patients with postmenopausal osteoporosis regardless of prior fracture status.." 13th Mediterranean Congress of Physical & Rehabilitation Medicine , Marrakesh, Morocco, p.40.
@conferencepaper{conferencepaper, author={İlke Çoşkun Benlidayı Et Al. }, title={Denosumab is effective among patients with postmenopausal osteoporosis regardless of prior fracture status.}, congress name={13th Mediterranean Congress of Physical & Rehabilitation Medicine}, city={Marrakesh}, country={Morocco}, year={2019}, pages={40} }